These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15503836)
1. Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration. Norquist JM; Fitzpatrick R; Jenkinson C Qual Life Res; 2004 Oct; 13(8):1409-14. PubMed ID: 15503836 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey. Jenkinson C; Fitzpatrick R; Swash M; Jones G Clin Rehabil; 2007 Mar; 21(3):266-72. PubMed ID: 17329284 [TBL] [Abstract][Full Text] [Related]
3. Rasch measurement in the assessment of amytrophic lateral sclerosis patients. Norquist JM; Fitzpatrick R; Jenkinson C J Appl Meas; 2003; 4(3):249-57. PubMed ID: 12904675 [TBL] [Abstract][Full Text] [Related]
4. Distribution-based criteria for change in health-related quality of life in Parkinson's disease. Fitzpatrick R; Norquist JM; Jenkinson C J Clin Epidemiol; 2004 Jan; 57(1):40-4. PubMed ID: 15019009 [TBL] [Abstract][Full Text] [Related]
5. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients. Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761 [TBL] [Abstract][Full Text] [Related]
6. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)]. Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837 [TBL] [Abstract][Full Text] [Related]
7. Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40). Jenkinson C; Peto V; Jones G; Fitzpatrick R Clin Rehabil; 2003 Jul; 17(4):380-5. PubMed ID: 12785246 [TBL] [Abstract][Full Text] [Related]
8. The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40): evidence for a method of imputing missing data. Jenkinson C; Harris R; Fitzpatrick R Amyotroph Lateral Scler; 2007 Apr; 8(2):90-5. PubMed ID: 17453636 [TBL] [Abstract][Full Text] [Related]
9. Validity and Reliability of the Turkish Version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire. Alankaya N; Tülek Z; Özakgül A; Kaya A; Dik A J Neurosci Nurs; 2019 Oct; 51(5):253-258. PubMed ID: 31469706 [TBL] [Abstract][Full Text] [Related]
10. Trends of quality of life changes in amyotrophic lateral sclerosis patients. Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598 [TBL] [Abstract][Full Text] [Related]
11. Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5). Jenkinson C; Norquist JM; Fitzpatrick R J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):242-5. PubMed ID: 12531959 [TBL] [Abstract][Full Text] [Related]
12. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5. Jenkinson C; Fitzpatrick R J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):70-3. PubMed ID: 11118250 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. Jenkinson C; Fitzpatrick R; Brennan C; Bromberg M; Swash M J Neurol; 1999 Nov; 246 Suppl 3():III16-21. PubMed ID: 10631656 [TBL] [Abstract][Full Text] [Related]
14. Quality of life in amyotrophic lateral sclerosis/motor neuron disease: a structured review. Epton J; Harris R; Jenkinson C Amyotroph Lateral Scler; 2009 Feb; 10(1):15-26. PubMed ID: 18752087 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Jenkinson C; Fitzpatrick R; Brennan C; Swash M Amyotroph Lateral Scler Other Motor Neuron Disord; 1999 Dec; 1(1):33-40. PubMed ID: 12365067 [TBL] [Abstract][Full Text] [Related]
16. The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients. Jenkinson C; Levvy G; Fitzpatrick R; Garratt A J Neurol Sci; 2000 Nov; 180(1-2):94-100. PubMed ID: 11090872 [TBL] [Abstract][Full Text] [Related]
17. Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies. Damiano AM; Patrick DL; Guzman GI; Gawel MJ; Gelinas DF; Natter HM; Ingalls KK Med Care; 1999 Jan; 37(1):15-26. PubMed ID: 10413388 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of the ALSAQ-5 scale in evaluation of quality of life in amyotrophic lateral sclerosis. Gołąb-Janowska M; Honczarenko K; Stankiewicz J Neurol Neurochir Pol; 2010; 44(6):560-6. PubMed ID: 21225518 [TBL] [Abstract][Full Text] [Related]
19. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5. Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637 [TBL] [Abstract][Full Text] [Related]
20. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data. Prell T; Gaur N; Steinbach R; Witte OW; Grosskreutz J Health Qual Life Outcomes; 2020 May; 18(1):117. PubMed ID: 32357946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]